PHARMA

Need to accelerate pharma commercialization?

Drive pharma product launch success with IQVIA Connected Intelligence™. Our portfolio integrates research, consulting, and AI-driven technology to fuel innovation and optimize patient outcomes.

Learn More

PHARMA

Maximize your product’s value through data strategy and AI.

Harness the power of IQVIA Healthcare-grade AI® and data-driven insights to enhance product value. Achieve growth, optimize ROI, navigate market complexities, and deliver outstanding business outcomes.

PHARMA

Accelerate lab-to-market milestones.

Expedite development and commercialization using data, technology, and deep domain expertise. Optimize your strategic path from lab to launch and beyond.

PHARMA

Seeking better patient outcomes?

Use patient feedback and digital tools to enhance treatment results. Map the complete patient journey from clinical trials to ongoing care, ensuring patients receive timely access to effective therapies.

Learn More

PHARMA

Your commercial strategy needs to be agile.

Enhance decision-making for commercial agility with IQVIA Connected Intelligence™ and predictive insights to adapt efficiently to market dynamics and deliver therapies effectively.

Build your pharma strategy for today's connected ecosystem.

Modern pharmaceutical success requires more than isolated excellence: it demands orchestration. When your data strategy, therapeutic insights, and commercial execution operate as one, everything changes. Market access accelerates. Patient outcomes improve. ROI multiplies. This isn't about adding more vendors; it's about finding a partner who sees the whole picture.  That's how breakthrough therapies become commercial triumphs.

How can connected healthcare unlock your newest competitive advantage?

Transform the complexity of fragmented data from evolving patient needs into an advantage. Discover how connected healthcare information enhances operations and customer engagement with deeper insights.

Need deep expertise for your specific therapy area?

Success hinges on understanding unique disease states, patients, and market dynamics. See how specialized knowledge translates into improved patient outcomes and successful launches.

Ready for a partner who drives commercial success?

Beyond vendors, successful launches demand true allies. Discover how a strategic partner who deeply understands your vision can transform challenges into commercial triumphs.

Require agility to navigate constant market changes?

As expectations continue to shift, upgrade your adaptability with a partner who anticipates changes. Our flexible models and responsive teams support everything from pharmaceutical asset management to contract manufacturing, promoting success across the value chain.

WHITE PAPER

Redefining Commercial Models Beyond 2025

The pharmaceutical industry is at an inflection point as the decade progresses. It’s time to re-evaluate legacy commercial models and discover how integrated health systems, patient involvement, and AI are shaping pharma's future.

GET THE INSIGHTS

Coordinate expert engagement

Create enduring congress experiences for both in-person and virtual attendees. Amplify key messages across channels while addressing HCP information overload through sustained engagement.

Truly measure congress impact

Ensure valuable expert interactions through cross-functional planning. Develop annual engagement plans to foster transparent partnerships with dedicated resources to track implementation.

Maximize content engagement and measurement

Establish clear objectives and collect data at every congress stage. Track scientific voice, HCP engagement, and social listening to evaluate strategies and gauge long-term impact.

MEDICAL AFFAIRS

Can your congress content work harder?

Seeking greater congress ROI? Learn three ways to maximize content reach, coordinate expert interactions, and implement measurement for impactful HCP engagement.

READ MORE

Powering innovation for exceptional pharma outcomes

IQVIA removes barriers to connected healthcare information by enabling innovative use cases through our comprehensive data assets.

Featured Episode

Seeking insights for agile pharma launches?

Gain expert perspectives on navigating commercial launches. Our podcast features industry leaders discussing challenges and actionable insights for successful launches in complex environments.

Launch Excellence: Episode 10 \ Achieving Oncology Launch Excellence

Explore strategies with our thought leaders to transform innovative oncology therapies into commercial successes. Gain insights on navigating the complexities of oncology launches in a rapidly evolving market to achieve excellence.

Can AI elevate patient support services?

Discover five early learnings from deploying AI in patient support. Understand how AI impacts agent workflows, enables personalization, and evolves performance metrics in patient support services.

Read More

Pharma capabilities

Data, AI, and expertise empower Commercial Solutions to optimize strategy, accelerate market access, and maximize brand performance.

Connect and Learn

Join industry experts exploring innovative solutions

Frequently Asked Questions

How do I develop a healthcare data strategy?

Successful data strategies require expertise across five key areas: integration, privacy and governance, tech-enabled insights, enterprise support, and panel resilience. Our comprehensive approach helps you address evolving use cases, as detailed in our Connected Healthcare Information eBook.

How should I structure my pharma marketing plan?

Effective plans blend market intelligence with targeted stakeholder engagement. Success means aligning personal field activities with digital initiatives while adapting to changing healthcare dynamics. Explore this topic in our Innovating a Pharma Commercial Model for the Future white paper.

How are pharma pricing strategies changing?

Modern pricing balances value demonstration with access requirements for patient reach and sustainable returns. Approaches include economic modeling and innovative contracting while adapting to policy landscapes, as discussed in our Market Access blog.